261-LB: Robotic Pancreas Kidney Transplantation for Type 1 Diabetic Patient with End-Stage Renal Disease: First Year Experience in Single Institute

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 261-LB
Author(s):  
SEUNG DUK LEE ◽  
LEIGH A. CANTRELL ◽  
JOSE OBERHOLZER
2017 ◽  
Vol 56 (205) ◽  
pp. 175-178
Author(s):  
Ren Qingqi ◽  
Ju Weiqiang ◽  
Wang Dongping ◽  
Guo Zhiyong ◽  
Chen Maogen ◽  
...  

Primary hyperoxaluria type 1 is an autosomal recessive hereditary glyoxylate metabolism disorder characterized by excessive production of oxalate, caused by the deficiency of liver specific peroxisomal enzyme: alanineglyoxylate aminotransferase. For patients with end-stage renal disease, combined liver and kidney transplantation was needed. This report describes one patient, with a diagnosis of end-stage renal disease and primary hyperoxaluria 1 confirmed by PCR and direct sequencing with genomic DNA, received the simultaneous combined liver and kidney transplantation after seven months’ waiting. However, there were several complications observed post surgery, such as protracted bleeding, common bile duct anastomotic stenosis, biliary calculi and recurrence of urolithiasis. All these were well solved by relevant department, and finally a satisfactory outcome was achieved. Multidisciplinary cooperation plays an important role on the PH1 patient management, especially when multiple complications are encountered. Keywords: primary hyperoxaluria type 1; end-stage renal disease; liver transplantation; kidney transplantation.


2013 ◽  
Vol 13 (8) ◽  
pp. 2207-2210 ◽  
Author(s):  
K. A. Benedict ◽  
S. Moassesfar ◽  
S. Adi ◽  
S. E. Gitelman ◽  
J. L. Brennan ◽  
...  

2014 ◽  
Vol 8 (3-4) ◽  
pp. 135 ◽  
Author(s):  
Alex Tianxiang Jiang ◽  
Neal Rowe ◽  
Alp Sener ◽  
Patrick Luke

Type 1 diabetes mellitus (DM) is one of the most common and debilitating diseases to affect the world. Many patients are afflicted by microvascular and macrovascular complications, and succumb to end-stage renal disease (ESRD). Although dialysis and insulin therapy provides better glycemic control, it nonetheless significantly decreases a patient’s quality of life. Moreover, they cannot reverse ESRD or alleviate complications. Simultaneous pancreas-kidney (SPK) transplantation has revolutionized the way we manage type 1 DM; it provides a physiological means of achieving normoglycemia while rendering patients free of dialysis. Understanding this procedure is important because it is becoming a more common management strategy for patients with type 1 DM. In this review, we will begin with a brief summary of type 1 DM, followed by a comprehensive description of SPK procedure, including the history and technique. We will then present the outcomes of transplantation.


Sign in / Sign up

Export Citation Format

Share Document